Back
Revance Therapeutics Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
10
RVNC
Revance Therapeutics
Last Price:
3.84
Seasonality Move:
2.15%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Revance Therapeutics Stock Forecast
-
Is Revance Therapeutics Stock Undervalued?
The current Revance Therapeutics [RVNC] share price is $3.84. The Score for RVNC is 10, which is 80% below its historic median score of 50, and infers higher risk than normal. - RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Revance Therapeutics Stock Go Up Next Year?
Data Unavailable
Revance Therapeutics Stock Rating
Data Unavailable
Revance Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
revance.com
52-Week Data
52-Week High:
9.75
52-Week Low:
2.30
Prediction Charts
Market Cap:
402.83M
Price in USD:
3.84
Volume:
683.17K
Beta:
1.01
Technical Analysis
SMA50:
5.22
SMA100:
5.01
SMA200:
4.61
52-Wk Change:
-46.89%
Stock Predictions
-
Is Revance Therapeutics stock public?
Yes, Revance Therapeutics is a publicly traded company. -
What is the Revance Therapeutics stock quote today?
The Revance Therapeutics stock price is 3.84 USD today. -
How to buy Revance Therapeutics stock online?
You can buy Revance Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-4 | 5.80 | 5.80 | 5.85 | 5.64 |
| Nov-5 | 5.80 | 5.84 | 5.90 | 5.73 |
| Nov-6 | 5.95 | 5.81 | 5.97 | 5.67 |
| Nov-7 | 5.80 | 5.78 | 5.90 | 5.73 |
| Nov-8 | 4.25 | 3.71 | 4.34 | 3.48 |
| Nov-11 | 3.75 | 3.44 | 3.90 | 3.36 |
| Nov-12 | 3.47 | 4.13 | 4.26 | 3.42 |
| Nov-13 | 4.12 | 4.25 | 4.29 | 4.00 |
| Nov-14 | 4.29 | 4.31 | 4.37 | 4.17 |
| Nov-15 | 4.30 | 4.17 | 4.30 | 4.14 |
| Nov-18 | 4.18 | 3.99 | 4.19 | 3.98 |
| Nov-19 | 3.96 | 3.76 | 4.01 | 3.64 |
| Nov-20 | 3.92 | 3.80 | 3.93 | 3.68 |
| Nov-21 | 3.77 | 3.84 | 3.88 | 3.76 |
Revance Therapeutics Earnings
Data Unavailable
Revance Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.
* Revance Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.